BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari John L Higgins. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa John L Higgins telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:TECH / Bio-Techne Corporation Director 65,236
US:OABI / OmniAb, Inc. Director 2,851,887
US:LGND / Ligand Pharmaceuticals Incorporated Director 417,695
US:BCRX / BioCryst Pharmaceuticals, Inc. Director 15,000
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh John L Higgins. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di BCRX / BioCryst Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Penjualan Orang Dalam BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di BCRX / BioCryst Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh John L Higgins sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-08-11 2025-08-07 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5,040 65,236 8.37 21.84 110,074 1,424,754
2025-06-18 2025-06-17 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 20,000 2,851,887 0.71
2025-05-13 2025-05-12 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 65,000 2,831,887 2.35 1.44 93,600 4,077,917
2025-05-05 2025-05-01 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 12,000 60,196 24.90 21.84 262,080 1,314,681
2025-03-21 2025-03-21 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 4,000 2,766,887 0.14 2.28 9,120 6,308,502
2025-03-20 2025-03-20 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 125,750 2,762,887 4.77 2.35 295,512 6,492,784
2025-01-30 2025-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13,172 2,637,137 0.50
2024-10-28 2024-10-24 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1,462 48,196 3.13
2024-09-16 2024-09-12 4 TECH BIO-TECHNE Corp
Common Stock
F - Taxes -1,874 46,734 -3.86 73.20 -137,177 3,420,929
2024-09-16 2024-09-12 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 6,000 48,608 14.08 22.95 137,700 1,115,554
2024-07-10 2024-07-08 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 6,000 42,608 16.39 22.95 137,700 977,854
2024-06-21 2024-06-18 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 20,000 2,623,965 0.77
2024-05-16 2024-05-14 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -4,000 36,608 -9.85 83.84 -335,377 3,069,372
2024-05-16 2024-05-14 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 4,000 40,608 10.93 22.95 91,800 931,954
2024-04-23 2022-11-01 4/A OABI OmniAb, Inc.
Common Stock
A - Award 2,427,861 2,603,965 1,378.65
2024-01-31 2024-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13,173 2,352,625 0.56
2023-10-30 2023-10-26 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1,625 36,608 4.65
2023-06-27 2023-01-04 4 OABI OmniAb, Inc.
Common Stock
F - Taxes 57,803 2,339,452 2.53 3.23 186,704 7,556,430
2023-06-27 2022-12-28 4 OABI OmniAb, Inc.
Common Stock
F - Taxes 25,914 2,397,255 1.09 3.66 94,845 8,773,953
2023-05-25 2023-05-23 4 OABI OmniAb, Inc.
Common Stock
S - Sale -9,000 2,462,686 -0.36 4.05 -36,450 9,973,878
2023-05-25 2023-05-23 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 9,000 2,471,686 0.37 3.68 33,120 9,095,804
2023-05-23 2023-05-19 4 OABI OmniAb, Inc.
Common Stock
S - Sale -1,000 2,462,686 -0.04 4.05 -4,050 9,973,878
2023-05-23 2023-05-19 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 1,000 2,463,686 0.04 3.68 3,680 9,066,364
2023-05-19 2023-05-18 4 OABI OmniAb, Inc.
Common Stock
S - Sale -50,000 2,462,686 -1.99 3.89 -194,500 9,579,849
2023-05-19 2023-05-18 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 50,000 2,512,686 2.03 3.68 184,000 9,246,684
2023-05-02 2023-04-28 4 TECH BIO-TECHNE Corp
Common Stock
F - Taxes -4,377 34,983 -11.12 79.88 -349,635 2,794,442
2023-05-02 2023-04-28 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 16,000 39,360 68.49 21.85 349,600 860,016
2023-02-01 2023-01-30 4 OABI OmniAb, Inc.
Common Stock
A - Award 39,517 2,462,686 1.63
2022-12-30 2022-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5,289 417,695 -1.25 66.29 -350,608 27,689,002
2022-12-20 2022-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 422,984 -2.31 61.87 -618,657 26,168,201
2022-12-14 2022-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -3,944 432,984 -0.90 64.80 -255,571 28,057,363
2022-12-14 2022-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 436,928 4.80 12.78 255,600 5,583,940
2022-12-01 2022-11-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -9,803 416,928 -2.30 72.90 -714,639 30,394,051
2022-11-21 2022-11-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 426,731 2.40 12.78 127,800 5,453,622
2022-11-21 2022-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 416,731 -2.34 78.32 -783,173 32,637,247
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 45,922 424,731 12.12
2022-11-03 2022-11-02 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 246,648 2,423,169 11.33 2.52 621,553 6,106,386
2022-11-03 2022-11-01 4 OABI OmniAb, Inc.
Common Stock
A - Award 2,176,521 2,176,521
2022-10-31 2022-10-27 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 338 5,840 6.14
2022-09-22 2022-09-16 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1,000 366,180 -0.27 88.06 -88,060 32,245,811
2022-09-16 2022-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,000 364,180 -0.82 89.35 -268,050 32,539,483
2022-09-16 2022-09-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,000 367,180 -0.54 90.00 -180,000 33,046,200
2022-08-12 2022-08-11 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -8 5,502 -0.15 380.71 -3,046 2,094,666
2022-08-12 2022-08-11 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -504 5,510 -8.38 385.47 -194,277 2,123,936
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -992 6,014 -14.16 380.15 -377,112 2,286,240
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -100 7,006 -1.41 374.90 -37,490 2,626,514
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -900 7,106 -11.24 373.99 -336,593 2,657,586
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 3,400 8,006 73.82 66.90 227,460 535,601
2022-07-06 2022-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 164 369,180 0.04 75.84 12,437 27,997,504
2022-06-14 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 20,423 369,016 5.86
2022-06-09 2022-06-08 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -600 4,606 -11.53 366.09 -219,654 1,686,211
2022-06-09 2022-06-08 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 600 5,206 13.03 66.90 40,140 348,281
2022-06-09 2022-06-07 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1,000 4,606 -17.84 364.31 -364,310 1,678,012
2022-06-09 2022-06-07 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 1,000 5,606 21.71 66.90 66,900 375,041
2022-05-10 2022-05-10 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
S - Sale 429,159.38
2022-05-10 2022-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8,000 57,616 -12.19
2022-05-10 2022-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 8,000 348,593 2.35 21.92 175,360 7,641,159
2022-05-09 2022-05-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 76,478 76,478
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,916 340,593 -0.56 123.68 -236,971 42,124,542
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,061 342,509 -0.60 123.68 -254,904 42,361,513
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,946 344,570 -0.56 123.68 -240,681 42,616,418
2022-02-07 2021-11-15 5 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -2,502 332,593 -0.75
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -6,183 349,018 -1.74 113.68 -702,883 39,676,366
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,060 355,201 -0.85 113.68 -347,861 40,379,250
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13,560 358,261 3.93
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9,606 344,701 2.87
2021-11-12 2021-11-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,000 335,095 -0.89 160.50 -481,500 53,782,748
2021-11-01 2021-10-28 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 633 633
2021-11-01 2021-10-28 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 194 4,606 4.40
2021-07-02 2021-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 247 338,095 0.07 85.91 21,220 29,045,572
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,061 337,848 -0.61 172.46 -355,440 58,265,266
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,947 339,909 -0.57 172.46 -335,780 58,620,706
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,204 341,856 -0.35 172.46 -207,642 58,956,486
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -54,666 14,334 -79.23
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -60,000 0 -100.00
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,970 343,060 -0.86 203.03 -602,999 69,651,472
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 60,000 346,030 20.98 10.05 603,000 3,477,602
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -54,666 286,030 -16.05 203.40 -11,119,239 58,179,417
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 54,666 340,696 19.11 14.47 791,017 4,929,871
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 25,113 25,113
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12,608 286,030 4.61
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -30,000 65,616 -31.38
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -40,000 69,000 -36.70
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 30,000 273,422 12.32 21.92 657,600 5,993,410
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -40,000 243,422 -14.11 182.00 -7,280,000 44,302,804
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 40,000 283,422 16.43 14.47 578,800 4,101,116
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -50,000 109,000 -31.45
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,596 243,422 -1.85 156.01 -717,022 37,976,266
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9,607 248,018 4.03
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,845 238,411 -1.18 156.01 -443,848 37,194,500
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5,946 241,256 2.53
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -50,000 235,310 -17.52 159.00 -7,950,000 37,414,290
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 50,000 285,310 21.25 14.47 723,500 4,128,436
2021-01-05 2020-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 223 235,310 0.09 84.53 18,851 19,891,343
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14,657 60,000 -19.63
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,683 235,087 -0.71 87.52 -147,296 20,574,814
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 14,657 236,770 6.60 10.05 147,303 2,379,538
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20,000 74,657 -21.13
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,458 222,113 -1.09 81.77 -200,991 18,162,180
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 224,571 9.78 10.05 201,000 2,256,939
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
M - Exercise -5,000 0 -100.00
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -3,100 4,412 -41.27 301.06 -933,301 1,328,297
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -450 7,512 -5.65 299.84 -134,928 2,252,392
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1,450 7,962 -15.41 298.98 -433,516 2,380,451
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5,000 9,412 113.33 70.35 351,750 662,134
2020-11-02 2020-10-29 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
A - Award 1,507 1,507
2020-11-02 2020-10-29 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 391 4,412 9.72
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1,165 54,226 -2.10
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1,373 93,627 -1.45
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1,777 54,421 -3.16
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,373 204,571 0.68 74.42 102,179 15,224,174
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,777 203,198 0.88 56.26 99,974 11,431,919
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,165 201,421 0.58 85.79 99,945 17,279,908
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,310 133,982 -0.97 120.86 -158,327 16,193,065
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,689 135,292 -1.23 120.86 -204,133 16,351,391
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,918 136,981 -1.38 120.86 -231,809 16,555,524
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,117 205,173 -1.02 97.23 -205,836 19,948,971
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,310 207,290 -0.63 97.23 -127,371 20,154,807
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,689 208,600 -0.80 97.23 -164,221 20,282,178
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -48,125 0 -100.00
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 60,886 60,886
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13,559 210,289 6.89
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5,009 196,730 -2.48 95.68 -479,261 18,823,126
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 48,125 201,739 31.33 9.96 479,325 2,009,320
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -5,000 4,021 -55.43 205.23 -1,026,132 825,216
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5,000 9,021 124.35 61.46 307,300 554,431
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,948 153,614 -1.88 105.87 -312,105 16,263,114
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5,946 156,562 3.95
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,801 150,616 -2.46 105.87 -402,412 15,945,716
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,668 154,417 5.23
2019-10-28 2019-10-24 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 2,011 2,011
2019-10-28 2019-10-24 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 495 4,021 14.04
2019-09-24 2019-09-19 4/A LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 988,468.75
2019-09-23 2019-09-19 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 841,250.00
2019-07-31 2019-07-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,850 146,749 1.28 95.45 176,582 14,007,192
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Stock Options (Right to buy)
M - Exercise -5,000 0 -100.00
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -5,000 3,526 -58.64 203.67 -1,018,346 718,137
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5,000 8,526 141.80 63.03 315,150 537,394
2019-05-31 2019-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 144,899 0.69 108.20 108,202 15,678,362
2019-05-14 2019-05-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2,500 143,899 1.77 113.50 283,750 16,332,536
2019-03-15 2019-03-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2,500 141,399 1.80 114.29 285,725 16,160,492
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 58,596 58,596
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12,809 138,899 10.16
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,168 126,090 -2.45 111.78 -354,119 14,094,340
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,390 129,258 5.20
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,597 122,868 -2.84 111.78 -402,073 13,734,185
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,256 126,465 6.09
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4,000 0 -100.00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -29,790 0 -100.00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 29,790 119,209 33.32 16.14 480,811 1,924,033
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4,000 89,419 4.68 16.14 64,560 1,443,223
2018-10-29 2018-10-25 4 TECH BIO-TECHNE Corp
Stock Options (Right to buy)
A - Award 1,898 1,898
2018-10-29 2018-10-25 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 514 3,526 17.07
2018-08-31 2018-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,500 85,419 -3.94 258.25 -903,875 22,059,457
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -10,000 3,012 -76.85 187.92 -1,879,173 566,007
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 10,000 13,012 332.01 61.08 610,800 794,773
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -12,993 159,000 -7.55
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12,993 88,919 -12.75 243.00 -3,157,299 21,607,317
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12,993 101,912 14.61 14.47 188,009 1,474,667
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3,007 171,993 -1.72
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -21,507 88,919 -19.48 241.33 -5,190,261 21,458,724
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,007 110,426 2.80 14.47 43,511 1,597,864
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -12,405 29,790 -29.40
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12,405 107,419 -10.35 179.97 -2,232,491 19,331,875
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12,405 119,824 11.55 16.14 200,217 1,933,959
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,982 107,419 -2.70 165.87 -494,624 17,817,590
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,015 110,401 5.76
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 41,392 41,392
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,928 104,386 8.22
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,689 96,458 -1.72 157.18 -265,477 15,161,268
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,918 98,147 -1.92 157.18 -301,471 15,426,745
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,635 100,065 -2.57 157.18 -414,169 15,728,217
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -9,000 102,700 -8.06 157.03 -1,413,279 16,127,084
2018-01-26 2018-01-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -22,500 111,700 -16.77 165.00 -3,712,500 18,430,500
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -16,249 42,195 -27.80
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -11,850 134,200 -8.11 151.92 -1,800,307 20,388,281
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -16,249 146,050 -10.01 155.00 -2,518,595 22,637,750
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 16,249 162,299 11.13 16.14 262,259 2,619,506
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5,199 146,050 -3.44 138.66 -720,893 20,251,293
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9,965 151,249 7.05
2017-11-20 2017-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,258 141,284 -1.57 140.34 -316,888 19,827,797
2017-11-17 2017-11-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5,269 143,542 -3.54 142.53 -750,991 20,459,041
2017-10-30 2017-10-26 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 3,125 3,125
2017-10-30 2017-10-26 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 739 3,012 32.51
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -11,384 0 -100.00
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,744 148,811 -1.16 143.04 -249,462 21,285,925
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 11,384 150,555 8.18 21.92 249,537 3,300,166
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -5,000 139,171 -3.47 130.00 -650,000 18,092,230
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 144,171 3.59 21.00 105,000 3,027,591
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -5,483 5,000 -52.30
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -5,483 139,171 -3.79 125.00 -685,375 17,396,375
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,483 144,654 3.94 21.00 115,143 3,037,734
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -4,666 0 -100.00
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4,666 139,171 -3.24 120.00 -559,920 16,700,520
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 4,666 143,837 3.35 21.00 97,986 3,020,577
2017-06-23 2008-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 4,666 4,666
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -12,000 10,483 -53.37
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12,000 139,171 -7.94 114.87 -1,378,440 15,986,573
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12,000 151,171 8.62 21.00 252,000 3,174,591
2017-03-21 2017-03-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4,000 139,171 -2.79 109.10 -436,400 15,183,556
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -15,675 0 -100.00
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,473 143,171 -1.02 106.92 -157,493 15,307,843
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 15,675 144,644 12.15 10.05 157,534 1,453,672
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4,000 128,969 -3.01 107.06 -428,240 13,807,421
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 43,646 43,646
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 10,224 132,969 8.33
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,783 122,745 -3.75 100.38 -480,118 12,321,143
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9,168 127,528 7.75
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,019 118,360 -1.68 104.28 -210,541 12,342,581
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,285 120,379 -1.86 104.28 -238,280 12,553,122
2016-10-31 2016-10-27 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 3,985 3,985
2016-10-31 2016-10-27 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 914 2,273 67.26
2016-09-23 2016-09-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,000 122,664 -2.39 117.34 -352,020 14,393,394
2016-09-12 2016-09-08 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1,700 1,359 -55.57 109.83 -186,716 149,263
2016-03-09 2016-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -6,000 22,483 -21.07
2016-03-09 2016-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6,000 125,664 5.01 21.00 126,000 2,638,944
2016-03-09 2016-03-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -556 119,664 -0.46 102.97 -57,251 12,321,802
2016-03-09 2016-03-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10,277 120,220 -7.88 102.44 -1,052,776 12,315,337
2016-02-16 2016-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,492 130,497 -1.87 85.97 -214,237 11,218,827
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 55,391 55,391
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 11,611 132,989 9.57
2015-11-02 2015-10-29 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
A - Award 4,260 4,260
2015-11-02 2015-10-29 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1,059 3,059 52.95
2015-08-07 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4,666 121,378 -3.70 110.79 -516,946 13,447,469
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -500 126,044 -0.40 95.06 -47,530 11,981,743
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3,300 126,544 -2.54 93.21 -307,593 11,795,166
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6,200 129,844 -4.56 92.53 -573,686 12,014,465
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 56,198 56,198 56.26 3,161,699 3,161,699
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 15,945 136,044 13.28
2014-11-03 2014-10-30 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 4,000 4,000
2014-11-03 2014-10-30 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1,000 2,000 100.00
2014-08-15 2014-08-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 120,099 0.84 54.97 54,970 6,601,842
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -16,875 48,125 -25.96
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10,000 95,000 11.76 74.42 744,200 7,069,900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10,000 95,000 11.76 74.42 744,200 7,069,900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 75,000 75,000 74.42 5,581,500 5,581,500
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8,000 119,099 7.20
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -16,875 111,099 -13.19 75.00 -1,265,625 8,332,425
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 16,875 127,974 15.19 9.96 168,075 1,274,621
2014-01-21 2014-01-21 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -9,000 28,483 -24.01 21.00 -189,000 598,143
2014-01-21 2014-01-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 9,000 111,099 8.81 21.00 189,000 2,333,079
2014-01-21 2014-01-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -15,000 102,099 -12.81 64.00 -960,000 6,534,336
2013-11-04 2013-10-31 4 TECH TECHNE CORP /MN/
Stock Option
A - Award 4,000 4,000
2013-11-04 2013-10-31 4 TECH TECHNE CORP /MN/
Common Stock
A - Award 1,000 1,000
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5,850 37,483 -13.50
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -4,668 15,675 -22.95
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4,668 117,099 4.15 10.05 46,913 1,176,845
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5,850 112,431 5.49 21.00 122,850 2,361,051
2013-10-22 2013-10-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 106,581 -8.58 55.00 -550,000 5,861,955
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -6,556 58,444 -10.09
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6,556 116,581 5.96 16.14 105,814 1,881,617
2013-08-20 2013-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10,000 110,025 -8.33 42.85 -428,500 4,714,571
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 14,334 14,334 32.00 458,688 458,688
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12,000 120,025 11.11
2013-06-04 2012-02-09 4/A LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 160,666 160,666 14.47 2,324,837 2,324,837
2013-06-04 2012-02-09 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,000 95,275 6.72
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 95,616 95,616 21.92 2,095,903 2,095,903
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 11,384 11,384 21.92 249,537 249,537
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8,000 120,025 7.14
2012-12-05 2012-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 112,025 1.82 18.03 36,060 2,019,811
2012-10-26 2012-10-25 4 TECH TECHNE CORP /MN/
Stock Option
A - Award 5,000 5,000
2012-08-14 2012-08-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 500 110,025 0.46 16.39 8,195 1,803,310
2012-07-03 2012-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1,250 109,525 1.15 10.12 12,654 1,108,776
2012-05-25 2012-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Automatic Stock Option Grant
A - Award 15,000 15,000
2012-05-08 2012-05-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 108,275 0.93 12.04 12,040 1,303,631
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 175,000 175,000 14.47 2,532,250 2,532,250
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 18,000 107,275 20.16
2012-01-06 2011-12-30 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 210 89,275 0.24 10.09 2,119 900,740
2004-05-18 3/A BCRX BIOCRYST PHARMACEUTICALS INC
None
0
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)